CLINICAL_TRIALS
trial_result
· 2014-02-07
Clinical Trial Update: Use of Galantamine and CDP-choline (Citicoline) to Treat Adults With Schizophrenia [Phase 2]
Summary
A Phase 2 trial evaluating galantamine in combination with CDP-choline for schizophrenia has completed, with results posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Georgetown University | Conditions: Schizophrenia | Phase 2 | Status: COMPLETED | Results posted: 2014-02-07